Specifically, under Aβ pathological conditions, TREM2 deficiency significantly promotes tau pathology progression and brain atrophy, potentially because TREM2 is involved in microglial transition from homeostatic to DAM and thus is protective in the context of Aβ pathology (Fig. 4b) [155–157]. Here, TREM2 is linked to Brain atrophy.